Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 31.3% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price was down 31.3% during trading on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares traded hands during trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The firm’s 50-day moving average is C$0.10 and its 200 day moving average is C$0.07. The firm has a market capitalization of C$23.01 million, a P/E ratio of -16.50 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.